We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+14.58%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$865M
AUM Growth
+$9.54M
(+1.1%)
Cap. Flow
-$78.4M
Cap. Flow
% of AUM
-9.07%
Top 10 Holdings %
Top 10 Hldgs %
8.56%
Holding
892
New
315
Increased
150
Reduced
128
Closed
299
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XP
XP
|
+$7.27M |
| 2 |
Constellation Brands
STZ
|
+$7.01M |
| 3 |
Eli Lilly
LLY
|
+$6.9M |
| 4 |
Automatic Data Processing
ADP
|
+$6.79M |
| 5 |
Nu Holdings
NU
|
+$6.73M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$11.9M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$11.9M |
| 3 |
Microsoft
MSFT
|
+$11.8M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$11.7M |
| 5 |
Las Vegas Sands
LVS
|
+$11.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.67% |
| 2 | Healthcare | 18.49% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Industrials | 10.31% |
| 5 | Financials | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Helen of Troy
HELE
$658M
| $486K | 0.06% |
+4,025
| New | +$434K |
|
427
Tenable Holdings
TENB
$3.96B
| $486K | 0.06% |
10,550
+3,014
| +40% | +$127K |
|
428
Cavco Industries
CVCO
$4.36B
| $485K | 0.06% |
1,399
+51
| +4% | +$14.5K |
|
429
Insperity
NSP
$2.02B
| $482K | 0.06% |
4,114
-1,862
| -31% | -$201K |
|
430
IBM
IBM
$222B
| $476K | 0.06% |
+2,908
| New | +$439K |
|
431
United Airlines
UAL
$43B
| $474K | 0.05% |
11,478
-25,553
| -69% | -$1M |
|
432
Gartner
IT
$12.4B
| $471K | 0.05% |
1,045
-4,168
| -80% | -$1.67M |
|
433
Bread Financial
BFH
$4.54B
| $467K | 0.05% |
14,173
-10,738
| -43% | -$321K |
|
434
Bank of Hawaii
BOH
$3.19B
| $463K | 0.05% |
+6,387
| New | +$366K |
|
435
FIVE9
FIVN
$2.28B
| $457K | 0.05% |
5,809
-9,953
| -63% | -$693K |
|
436
AtriCure
ATRC
$1.98B
| $455K | 0.05% |
+12,762
| New | +$475K |
|
437
Entergy
ETR
$50.8B
| $455K | 0.05% |
+8,992
| New | +$439K |
|
438
Abbott
ABT
$182B
| $453K | 0.05% |
4,115
-7,300
| -64% | -$729K |
|
439
KB Home
KBH
$3.56B
| $453K | 0.05% |
+7,250
| New | +$373K |
|
|
SAGE
440
DELISTED
Sage Therapeutics
SAGE
| $453K | 0.05% |
20,884
-21,748
| -51% | -$431K |
|
441
O-I Glass
OI
$1.16B
| $452K | 0.05% |
27,625
-55,687
| -67% | -$858K |
|
442
DuPont de Nemours
DD
$19.3B
| $449K | 0.05% |
+4,647
| New | +$423K |
|
443
Hormel Foods
HRL
$13.9B
| $449K | 0.05% |
13,972
-18,863
| -57% | -$616K |
|
444
Walmart Inc
WMT
$888B
| $444K | 0.05% |
+8,454
| New | +$447K |
|
|
SWN
445
DELISTED
Southwestern Energy Company
SWN
| $443K | 0.05% |
+67,570
| New | +$451K |
|
446
Vodafone
VOD
$36.3B
| $437K | 0.05% |
+50,243
| New | +$459K |
|
447
Mondelez International
MDLZ
$79.2B
| $433K | 0.05% |
+5,984
| New | +$410K |
|
|
AVDX
448
DELISTED
AvidXchange
AVDX
| $432K | 0.05% |
+34,893
| New | +$349K |
|
|
VTLE
449
DELISTED
Vital Energy
VTLE
| $429K | 0.05% |
+9,441
| New | +$453K |
|
450
Service Corp International
SCI
$11.7B
| $429K | 0.05% |
6,264
-17,520
| -74% | -$1.05M |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q4 2023 Portfolio in Review
As of Q4 2023, Seven Eight Capital held 892 positions worth $865M, up 1.1% from $855M the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.
Seven Eight Capital withdrew a net $78.4M in Q4 2023, closing 299 positions and reducing 128 holdings. Its most notable exit was Merck, an estimated $11.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Seven Eight Capital opened a new position in XP worth $8.3M.
- Seven Eight Capital's largest Q4 2023 buy was XP: 318,542 shares worth $8.3M.
- Seven Eight Capital added most to Constellation Brands in Q4 2023, an estimated $7.01M increase.
- Seven Eight Capital's biggest Q4 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $11.9M.
- Seven Eight Capital fully exited Merck in Q4 2023, selling an estimated $11.9M.
- Seven Eight Capital's ten largest holdings make up 8.6% of its $865M portfolio in Q4 2023.
- Seven Eight Capital opened 315 new positions and closed 299 in Q4 2023.
- Seven Eight Capital's portfolio value rose 1.1% quarter-over-quarter to $865M.
Based on Seven Eight Capital's 13F filing for Q4 2023, filed 13 Feb 2024.